CN104013682B - A kind of Traditional Chinese medicine bacteriostatic composition suppressing micrococcus luteus - Google Patents
A kind of Traditional Chinese medicine bacteriostatic composition suppressing micrococcus luteus Download PDFInfo
- Publication number
- CN104013682B CN104013682B CN201410052640.7A CN201410052640A CN104013682B CN 104013682 B CN104013682 B CN 104013682B CN 201410052640 A CN201410052640 A CN 201410052640A CN 104013682 B CN104013682 B CN 104013682B
- Authority
- CN
- China
- Prior art keywords
- silver
- water
- radix
- extract
- micrococcus luteus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
技术领域 technical field
本发明属于中药领域,尤其涉及一种中药抑菌组合物。 The invention belongs to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine antibacterial composition.
背景技术 Background technique
大黄是多种蓼科大黄属的多年生植物的合称,也是中药材的名称。因其喜冷凉气候,且耐寒,故其主要生于山地林缘或草坡的阴湿环境,中药大黄具有攻积滞、清湿热、泻火、凉血、祛瘀、解毒等功效。现代药理研究证明,大黄具有抗菌作用,其中对于金黄色葡萄球菌、大肠杆菌、绿脓杆菌、伤寒沙门菌、痢疾杆菌、溶血性链球菌、肺炎球菌、白喉杆菌、炭疽杆菌、变形杆菌等都有较强的抑制作用,除此之外,还具有抗肿瘤、降低血压、健胃、利胆、保肝、强心、延缓衰老、调节免疫功能等作用。大黄因其具有较高的药用和保健价值,广泛引起了人们关注。 Rhubarb is a collective name for various perennial plants of the Polygonaceae Rhubarb genus, and it is also the name of Chinese medicinal materials. Because it likes a cool climate and is resistant to cold, it mainly grows in the damp environment on the edge of mountain forests or grass slopes. The traditional Chinese medicine rhubarb has the functions of attacking stagnation, clearing damp and heat, purging fire, cooling blood, removing blood stasis, and detoxifying. Modern pharmacological studies have proved that rhubarb has antibacterial effects, including Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Salmonella typhi, Shigella, hemolytic streptococcus, pneumococcus, diphtheria bacillus, Bacillus anthracis, Proteus, etc. Strong inhibitory effect, in addition, it also has the effects of anti-tumor, lowering blood pressure, invigorating the stomach, promoting gallbladder, protecting the liver, strengthening the heart, delaying aging, and regulating immune function. Rhubarb has attracted people's attention because of its high medicinal and health value.
中药制剂浓缩液制成口服液或抑菌剂、涂覆剂等一次用剂量大,且长期使用影响人体健康。 Concentrated Chinese medicine preparations made into oral liquids or antibacterial agents, coating agents, etc. have a large dosage at one time, and long-term use will affect human health.
发明内容 Contents of the invention
针对大黄抑菌剂一次用量大和长期使用影响人体健康问题,本发明人经过大量实验,发现纳米银能有效增强大黄提取液抑菌性能,减少大黄抑菌剂的用量,且采用两种低剂量的抑菌组合物,更加的安全。本发明的目的在于提供一种大黄纳米银抑菌组合物,减少大黄抑菌剂一次的用剂量和降低药品对人体的毒性。 Aiming at the large amount of rhubarb bacteriostatic agent once used and the long-term use affecting human health, the inventor found through a large number of experiments that nano-silver can effectively enhance the antibacterial performance of rhubarb extract, reduce the amount of rhubarb bacteriostatic agent, and use two low-dose The antibacterial composition is safer. The object of the present invention is to provide a rhubarb nano-silver bacteriostatic composition, which can reduce the once-used dose of rhubarb bacteriostatic agent and reduce the toxicity of medicine to human body.
本发明提供如下技术方案: The present invention provides following technical scheme:
一种抑菌组合物,含有大黄提取液、水溶性纳米银; An antibacterial composition, containing rhubarb extract and water-soluble nano-silver;
大黄提取液制备包括如下步骤:加水量为大黄重量的9倍,经95℃水浴提取4h,再经过减压浓缩得到提取液。所得提取液经0.22μm滤膜过滤。最后提取液经高效液相色谱法对大黄素进行标准定量。 The preparation of the rhubarb extract comprises the following steps: adding water in an amount 9 times the weight of the rhubarb, extracting in a water bath at 95°C for 4 hours, and then concentrating under reduced pressure to obtain the extract. The resulting extract was filtered through a 0.22 μm membrane filter. Finally, the extract was subjected to standard quantification of emodin by high performance liquid chromatography.
水溶性纳米银颗粒粒径为3~10nm,纳米银外表包覆两性聚合物。 The particle size of the water-soluble nano-silver particle is 3-10nm, and the surface of the nano-silver is coated with an amphoteric polymer.
水溶性纳米银粒径为3~10nm,外表为羧基,依照下列方法制备:取22.8g十四烷酸溶于140mL按2:5比例混合的甲醇和水中,向溶液中加入4g的氢氧化钠析出沉淀,过滤,将沉淀加入到100mL浓度为10mol/L水溶性的硝酸银溶液中得到十四烷酸银;称取6.7g浓度为20mmoL/L十四烷酸银于100mL烧杯中,向烧杯中加入58mL浓度为40mmoL/L的三乙胺,80℃下电磁搅拌2h,白色的十四烷酸银粉末逐渐变成棕色,不溶的前体消失,加入20mL丙酮沉淀析出,抽滤,用丙酮洗涤沉淀数次后,真空干燥,即得到纳米银粒子粉末。依照本方法制备的水溶性纳米银颗粒与大黄提取液具有良好的的协同抗菌作用。 The water-soluble nano-silver has a particle size of 3-10nm and a carboxyl group on the outside. It is prepared according to the following method: dissolve 22.8g of myristic acid in 140mL of methanol and water mixed in a ratio of 2:5, and add 4g of sodium hydroxide to the solution Precipitate, filter, and add the precipitate to 100mL concentration of 10mol/L water-soluble silver nitrate solution to obtain silver myristate; take 6.7g concentration of 20mmoL/L silver myristate in a 100mL beaker, and add to the beaker Add 58mL of triethylamine with a concentration of 40mmoL/L to the solution, stir electromagnetically at 80°C for 2h, the white silver myristate powder gradually turns brown, and the insoluble precursor disappears, add 20mL of acetone to precipitate, filter with acetone After washing the precipitate several times, it is dried in vacuum to obtain nano silver particle powder. The water-soluble nano-silver particle prepared according to the method has good synergistic antibacterial effect with rhubarb extract.
抑制大肠杆菌O157:H7时大黄提取液、水溶性纳米银的体积比为75~100:1 When inhibiting Escherichia coli O157:H7, the volume ratio of rhubarb extract and water-soluble nano-silver is 75-100:1
抑制藤黄微球菌时大黄提取液、水溶性纳米银的体积比为和25~50:1。 When inhibiting Micrococcus luteus, the volume ratio of rhubarb extract and water-soluble nano-silver is 25-50:1.
本发明还涉及上述抑菌组合物在抑制大肠杆菌O157:H7中的应用。 The present invention also relates to the application of the above antibacterial composition in inhibiting Escherichia coli O157:H7.
本发明还涉及上述抑菌组合物在抑制藤黄微球菌中的应用 The present invention also relates to the application of the above antibacterial composition in inhibiting Micrococcus luteus
本发明的有益效果是:水溶性纳米银的应用能有效增强大黄抑菌性能,降低大黄抑菌剂的用量,令人意向不到的是,两种药物的合用对抑制大肠杆菌O157:H7和藤黄微球菌起到协同作用,同时本抑菌组合物采用两种低剂量的抑菌物质,相对于使用高剂量的大黄或者水溶性纳米银,更加的安全,可以作为安全可靠地外用涂覆剂等。 The beneficial effects of the present invention are: the application of water-soluble nano-silver can effectively enhance the rhubarb bacteriostatic performance, reduce the consumption of rhubarb bacteriostatic agents, and what is unexpected is that the combined use of two kinds of medicines can inhibit Escherichia coli O157:H7 and Micrococcus luteus plays a synergistic effect. At the same time, the antibacterial composition uses two low-dose antibacterial substances, which is safer than the use of high-dose rhubarb or water-soluble nano-silver, and can be used as a safe and reliable external coating agent etc.
附图说明 Description of drawings
图1大黄提取液与纳米银之比为100:1对大肠杆菌O157:H7协同抑菌作用 Figure 1 The ratio of rhubarb extract to nano-silver is 100:1 for synergistic antibacterial effect on Escherichia coli O157:H7
图1a200μL大黄提取液对大肠杆菌O157:H7的抑制作用,图1b2μL的纳米银对大肠杆菌O157:H7的抑制作用,图1c100μL大黄提取液与1μL纳米银对大肠杆菌O157:H7的协同抑菌作用。 Figure 1a The inhibitory effect of 200 μL rhubarb extract on Escherichia coli O157:H7, Figure 1b The inhibitory effect of 2 μL nano-silver on Escherichia coli O157:H7, Figure 1c The synergistic antibacterial effect of 100 μL rhubarb extract and 1 μL nano-silver on Escherichia coli O157:H7 .
图2大黄提取液与纳米银之比为75:1对大肠杆菌O157:H7协同抑菌作用 Figure 2 The ratio of rhubarb extract to nano-silver is 75:1 for synergistic antibacterial effect on Escherichia coli O157:H7
图2a150μL大黄提取液对大肠杆菌O157:H7的抑制作用,图2b2μL的纳米银对大肠杆菌O157:H7的抑制作用,图2c75μL大黄提取液和1μL纳米银对大肠杆菌O157:H7的协同抑菌作用。 Figure 2a The inhibitory effect of 150 μL rhubarb extract on Escherichia coli O157:H7, Figure 2b The inhibitory effect of 2 μL nano-silver on Escherichia coli O157:H7, Figure 2c The synergistic antibacterial effect of 75 μL rhubarb extract and 1 μL nano-silver on Escherichia coli O157:H7 .
图3大黄提取液与纳米银之比为50:1对藤黄微球菌协同抑菌作用 Figure 3 The ratio of rhubarb extract to nano-silver is 50:1 for synergistic antibacterial effect on Micrococcus luteus
图3a800μL大黄提取液对藤黄微球菌的抑制作用,图3b16μL的纳米银对藤黄微球菌的抑制作用,图3c400μL大黄提取液和8μL纳米银藤黄微球菌协同抑菌作用。 Figure 3a The inhibitory effect of 800 μL rhubarb extract on M. luteus, Figure 3b The inhibitory effect of 16 μL nano-silver on M. luteus, Figure 3c The synergistic antibacterial effect of 400 μL rhubarb extract and 8 μL nano-silver on M. luteus.
图4大黄提取液与纳米银之比为25:1对藤黄微球菌协同抑菌作用 Figure 4 The ratio of rhubarb extract to nano-silver is 25:1 for synergistic antibacterial effect on Micrococcus luteus
图4a400μL大黄提取液对藤黄微球菌的抑制作用,图4b16μL的纳米银对藤黄微球菌的抑制作用,图4c200μL大黄提取液和8μL纳米银藤黄微球菌协同抑菌作用。 Figure 4a The inhibitory effect of 400 μL rhubarb extract on M. luteus, Figure 4b The inhibitory effect of 16 μL nano-silver on M. luteus, Figure 4c The synergistic antibacterial effect of 200 μL rhubarb extract and 8 μL nano-silver on M. luteus.
具体实施方式 Detailed ways
实施例1 Example 1
1、大黄提取液的制备过程: 1. The preparation process of rhubarb extract:
称取大黄50g,加水量为450mL,在95℃下提取4h,经过真空旋转浓缩仪后,用0.22μm滤膜除去提取液中的杂质和细菌,最后用高效液相色谱法测得提取液中大黄素含量为1.92μg/g。 Weigh 50g of rhubarb, add 450mL of water, extract at 95°C for 4h, pass through a vacuum rotary concentrator, use a 0.22μm filter to remove impurities and bacteria in the extract, and finally measure the concentration of the extract in the extract by high performance liquid chromatography. The content of emodin is 1.92μg/g.
2、水溶性银纳米颗粒制备 2. Preparation of water-soluble silver nanoparticles
取22.8g十四烷酸溶于140mL按2:5比例混合的甲醇和水中,向溶液中加入4g的氢氧化钠析出沉淀,过滤,将沉淀加入到100mL浓度为10mol/L水溶性的硝酸银溶液中得到十四烷酸银;称取6.7g浓度为20mmoL/L十四烷酸银于100mL烧杯中,向烧杯中加入58mL浓度为40mmoL/L的三乙胺,80℃下电磁搅拌2h,白色的十四烷酸银粉末逐渐变成棕色,不溶的前体消失,加入20mL丙酮沉淀析出,抽滤,用丙酮洗涤沉淀数次后,真空干燥,即得到纳米银粒子粉末。 Take 22.8g of myristic acid and dissolve 140mL of methanol and water mixed in a ratio of 2:5, add 4g of sodium hydroxide to the solution to precipitate, filter, and add the precipitate to 100mL of 10mol/L water-soluble silver nitrate Silver myristate was obtained in the solution; 6.7g of silver myristate with a concentration of 20mmoL/L was weighed in a 100mL beaker, and 58mL of triethylamine with a concentration of 40mmoL/L was added to the beaker, and electromagnetically stirred at 80°C for 2h. The white silver myristate powder gradually turns brown, and the insoluble precursor disappears. Add 20 mL of acetone to precipitate, filter with suction, wash the precipitate with acetone several times, and dry in vacuum to obtain nano silver particle powder.
3、大黄提取液与水溶性纳米银协同抑菌作用。 3. The synergistic antibacterial effect of rhubarb extract and water-soluble nano-silver.
a、细菌的培养 a. Culture of bacteria
挑取LB琼脂培养基上的大肠杆菌O157:H7的单菌落于10mLLB肉汤培养基中,置于37℃培养箱中培养16h,再按1%的接种量接种于5mL的LB肉汤培养基中,37℃培养4h后。取1mL上述菌液用0.1%的蛋白胨水连续稀释三个梯度,最终的菌液大约为106CFU/mL。 Pick a single colony of Escherichia coli O157:H7 on LB agar medium and place it in 10 mL of LB broth medium, culture it in a 37°C incubator for 16 hours, and then inoculate it into 5 mL of LB broth medium at an inoculum size of 1%. After incubation at 37°C for 4 h. Take 1mL of the above bacterial solution and serially dilute three gradients with 0.1% peptone water, and the final bacterial solution is about 10 6 CFU/mL.
b、水溶性纳米银与大黄提取液在抑菌性能上的协同作用 b. The synergistic effect of water-soluble nano-silver and rhubarb extract on antibacterial properties
分别取1mL上述已稀释好的菌液于1.5mL灭菌的离心管中,向1号离心管中分别加入200μL大黄提取液(大黄素含量为1.92μg/g,下同),向2号离心管中加入2μL浓度为10mg/mL的水溶性纳米银,向3号离心管中加入100μL大黄提取液和1μL浓度为10mg/mL水溶性纳米银,4号离心管作为空白对照,不加入任何上述抑菌剂。为保证每管液体最终体积相等,差量用0.1%的蛋白胨水补齐,置于37℃摇床培养箱培养2h。每组实验平行三次。 Take 1 mL of the above-mentioned diluted bacterial solution into 1.5 mL sterilized centrifuge tubes, add 200 μL of rhubarb extract (emodin content is 1.92 μg/g, the same below) to No. 1 centrifuge tube, and centrifuge to No. 2 Add 2 μL of water-soluble nano-silver with a concentration of 10 mg/mL to the tube, add 100 μL of rhubarb extract and 1 μL of water-soluble nano-silver with a concentration of 10 mg/mL to No. 3 centrifuge tube, and No. 4 centrifuge tube as a blank control without adding any of the above antibacterial agent. In order to ensure that the final volume of each tube of liquid is equal, the difference is made up with 0.1% peptone water, and placed in a shaker incubator at 37°C for 2 hours. Each experiment was performed in parallel three times.
c、平板计数 c. Plate count
将实验组待测液用PBS连续稀释两个梯度,100、10-1、10-2各取出200μL分别均匀涂布在 The solution to be tested in the experimental group was serially diluted in two gradients with PBS, and 200 μL of each of 10 0 , 10 -1 , and 10 -2 was taken out and spread evenly on the
LB固体平板上;空白组连续稀释四个梯度,从10-2、10-3、10-4三个梯度分别均涂布在LB On the LB solid plate; the blank group was serially diluted with four gradients, and the three gradients from 10 -2 , 10 -3 , and 10 -4 were all coated on LB
固体平板上。平板吹干后,37℃倒置培养12h,长出菌落后计数,以30-300个菌落形成单 on a solid plate. After drying the plate, culture it upside down at 37°C for 12 hours, count the colonies after they grow out, and form a single colony with 30-300 colonies.
位(CFU)为有效的计数范围。每毫升原菌液活菌数=平板计数*稀释倍数*5 Bits (CFU) are valid counting ranges. The number of viable bacteria per milliliter of the original bacterial solution = plate count * dilution factor * 5
实验结果如下: The experimental results are as follows:
如图1所示,图1a200μL大黄提取液对大肠杆菌O157:H7的抑制作用,图1b2μL的纳米银对大肠杆菌O157:H7的抑制作用,图1c100μL大黄提取液与1μL纳米银对大肠杆菌O157:H7的协同抑菌作用。 As shown in Figure 1, Figure 1a shows the inhibitory effect of 200 μL rhubarb extract on Escherichia coli O157:H7, Figure 1b shows the inhibitory effect of 2 μL rhubarb extract on Escherichia coli O157:H7, Figure 1c shows the inhibitory effect of 100 μL rhubarb extract and 1 μL nano silver on Escherichia coli O157: Synergistic antibacterial effect of H7.
实验表明:本发明提供的抑菌组合物具有减少大黄抑菌剂一次用量的作用,且两种药物的合用对抑制大肠杆菌O157:H7起到协同的作用。 Experiments show that the bacteriostatic composition provided by the invention has the effect of reducing the one-time dosage of rhubarb bacteriostatic agents, and the combination of the two drugs has a synergistic effect on inhibiting Escherichia coli O157:H7.
实施例2 Example 2
1、大黄提取液的制备过程: 1. The preparation process of rhubarb extract:
同实施例1。 With embodiment 1.
2、水溶性银纳米颗粒制备 2. Preparation of water-soluble silver nanoparticles
同实施例1。 With embodiment 1.
3、大黄提取液与水溶性纳米银协同抑菌作用。 3. The synergistic antibacterial effect of rhubarb extract and water-soluble nano-silver.
a、细菌的培养 a. Culture of bacteria
挑取LB琼脂培养基上的大肠杆菌O157:H7的单菌落于10mLLB肉汤培养基中,置于37℃培养箱中培养16h,再按1%的接种量接种于5mL的LB肉汤培养基中,37℃培养4h后。取1mL上述菌液用0.1%的蛋白胨水连续稀释三个梯度,最终的菌液大约为106CFU/mL。 Pick a single colony of Escherichia coli O157:H7 on LB agar medium and place it in 10 mL of LB broth medium, culture it in a 37°C incubator for 16 hours, and then inoculate it into 5 mL of LB broth medium at an inoculum size of 1%. After incubation at 37°C for 4 h. Take 1mL of the above bacterial solution and serially dilute three gradients with 0.1% peptone water, and the final bacterial solution is about 10 6 CFU/mL.
b、水溶性纳米银与大黄提取液在抑菌性能上的协同作用 b. The synergistic effect of water-soluble nano-silver and rhubarb extract on antibacterial properties
分别取1mL上述已稀释好的菌液于1.5mL灭菌的离心管中,向1号离心管中分别加入150μL大黄提取液,向2号离心管中加入2μL浓度为10mg/mL的水溶性纳米银,向3号离心管中加入75μL大黄提取液与1μL浓度为10mg/mL的水溶性纳米银,4号离心管作为空白对照,不加入任何上述抑菌剂。为保证每管液体最终体积相等,差量用0.1%的蛋白胨水补齐,置于37℃摇床培养箱培养2h。每组实验平行三次。 Take 1 mL of the above-mentioned diluted bacterial solution in 1.5 mL sterilized centrifuge tubes, add 150 μL of rhubarb extract to No. 1 centrifuge tube, and add 2 μL of water-soluble nano For silver, add 75 μL of rhubarb extract and 1 μL of water-soluble nano-silver with a concentration of 10 mg/mL to No. 3 centrifuge tube, and No. 4 centrifuge tube is used as a blank control without adding any of the above-mentioned antibacterial agents. In order to ensure that the final volume of each tube of liquid is equal, the difference is made up with 0.1% peptone water, and placed in a shaker incubator at 37°C for 2 hours. Each experiment was performed in parallel three times.
c、平板计数 c. Plate count
将实验组待测液用PBS连续稀释两个梯度,100、10-1、10-2各取出200μL分别均匀涂布在 The solution to be tested in the experimental group was serially diluted in two gradients with PBS, and 200 μL of each of 10 0 , 10 -1 , and 10 -2 was taken out and spread evenly on the
LB固体平板上;空白组连续稀释四个梯度,从10-2、10-3、10-4三个梯度分别均涂布在LB On the LB solid plate; the blank group was serially diluted with four gradients, and the three gradients from 10 -2 , 10 -3 , and 10 -4 were all coated on LB
固体平板上。平板吹干后,37℃倒置培养12h,长出菌落后计数,以30-300个菌落形成单 on a solid plate. After drying the plate, culture it upside down at 37°C for 12 hours, count the colonies after they grow out, and form a single colony with 30-300 colonies.
位(CFU)为有效的计数范围。每毫升原菌液活菌数=平板计数*稀释倍数*5 Bits (CFU) are valid counting ranges. The number of viable bacteria per milliliter of the original bacterial solution = plate count * dilution factor * 5
实验结果如下: The experimental results are as follows:
如图2所示,图2a150μL大黄提取液对大肠杆菌O157:H7的抑制作用,图2b2μL的纳米银对大肠杆菌O157:H7的抑制作用,图2c75μL大黄提取液和1μL纳米银对大肠杆菌O157:H7的协同抑菌作用。 As shown in Figure 2, Figure 2a shows the inhibitory effect of 150 μL rhubarb extract on Escherichia coli O157:H7, Figure 2b shows the inhibitory effect of 2 μL rhubarb extract on Escherichia coli O157:H7, and Figure 2c shows the inhibitory effect of 75 μL rhubarb extract and 1 μL nanosilver on Escherichia coli O157: Synergistic antibacterial effect of H7.
实验表明:本发明提供的抑菌组合物具有减少大黄抑菌剂一次用量的作用,且两种药物的合用对抑制大肠杆菌O157:H7起到协同的作用。 Experiments show that the bacteriostatic composition provided by the invention has the effect of reducing the one-time dosage of rhubarb bacteriostatic agents, and the combination of the two drugs has a synergistic effect on inhibiting Escherichia coli O157:H7.
实施例3 Example 3
1、大黄提取液的制备过程: 1. The preparation process of rhubarb extract:
同实施例1。 With embodiment 1.
2、水溶性银纳米颗粒制备 2. Preparation of water-soluble silver nanoparticles
同实施例1。 With embodiment 1.
3、大黄提取液与水溶性纳米银协同抑菌作用。 3. The synergistic antibacterial effect of rhubarb extract and water-soluble nano-silver.
a、细菌的培养 a. Culture of bacteria
挑取牛肉膏蛋白胨琼脂培养基上的藤黄微球菌单菌落于5mL牛肉膏蛋白胨液体培养基中,置于30℃培养箱中培养24h,再按1%的接种量接种于5mL的牛肉膏蛋白胨液体培养基中,30℃培12h后。取1mL上述菌液在用PBS与液体培养基按4:1比例混合的混合液中连续稀释三个梯度,最终的菌液大约为106~107CFU/mL。 Pick a single colony of Micrococcus luteus on the beef extract peptone agar medium, put it in 5mL beef extract peptone liquid medium, culture it in a 30°C incubator for 24 hours, and then inoculate 5mL of beef extract peptone according to the inoculation amount of 1%. In liquid medium, cultured at 30°C for 12h. Take 1mL of the above bacterial solution and serially dilute three gradients in the mixture of PBS and liquid medium at a ratio of 4:1, and the final bacterial solution is about 10 6 -10 7 CFU/mL.
b、水溶性纳米银与大黄提取液在抑菌性能上的协同作用 b. The synergistic effect of water-soluble nano-silver and rhubarb extract on antibacterial properties
分别取1mL上述已稀释好的菌液于1.5mL灭菌的离心管中,向1号离心管中分别加入800μL大黄提取液(其中只加菌液500μL),向2号离心管中加入16μL浓度为10mg/mL的水溶性纳米银,向3号离心管中加入400μL大黄提取液和8μL浓度为10mg/mL的水溶性纳米银,4号离心管作为空白对照,不加入任何上述抑菌剂。为保证每管液体最终体积相等,差量用PBS与液体培养基按4:1比例混合的混合液补齐。置于30℃摇床培养箱培养6h,每组实验平行三次。 Take 1mL of the above-mentioned diluted bacterial solution into 1.5mL sterilized centrifuge tubes, add 800μL of rhubarb extract (500μL of bacteria solution only) to No. 400 μL of rhubarb extract and 8 μL of water-soluble nano-silver with a concentration of 10 mg/mL were added to No. 3 centrifuge tube, and No. 4 centrifuge tube was used as a blank control without adding any of the above-mentioned antibacterial agents. In order to ensure that the final volume of each tube of liquid is equal, the difference is made up with a mixture of PBS and liquid medium at a ratio of 4:1. Placed in a shaker incubator at 30°C for 6 hours, and each experiment was repeated three times.
c、平板计数 c. Plate count
将实验组待测液用PBS连续稀释两个梯度,10-1、10-2、10-3各取出100μL分别均匀涂 The solution to be tested in the experimental group was serially diluted in two gradients with PBS, and 100 μL of each of 10 -1 , 10 -2 , and 10 -3 was taken out and spread evenly.
布在牛肉膏蛋白胨固体平板上;空白组连续稀释四个梯度,从10-2、10-3、10-4三个梯度分别均匀涂布在牛肉膏蛋白胨固体平板上。平板吹干后,30℃倒置培养48h,长出菌落后计数,以20-200个菌落形成单位(CFU)为有效的计数范围。每毫升原菌液活菌数=平板计数*稀释倍数*10 Spread on the beef extract peptone solid plate; the blank group was serially diluted with four gradients, and spread evenly on the beef extract peptone solid plate from three gradients of 10 -2 , 10 -3 , and 10 -4 respectively. After drying the plate, culture it upside down at 30°C for 48 hours, count the colonies after they grow out, and take 20-200 colony forming units (CFU) as the effective counting range. The number of viable bacteria per milliliter of original bacterial solution = plate count * dilution factor * 10
如图3所示,图3a800μL大黄提取液对藤黄微球菌的抑制作用,图3b16μL的纳米银对藤黄微球菌的抑制作用,图3c400μL大黄提取液和8μL纳米银藤黄微球菌协同抑菌作用。 As shown in Figure 3, Figure 3a shows the inhibitory effect of 800 μL rhubarb extract on Micrococcus luteus, Figure 3b shows the inhibitory effect of 16 μL nano-silver on Micrococcus luteus, and Figure 3c shows the synergistic antibacterial effect of 400 μL rhubarb extract and 8 μL nano-silver on Micrococcus luteus effect.
实验表明:本发明提供的抑菌组合物具有减少大黄抑菌剂一次用量的作用,且两种药物的合用对抑制藤黄微球菌起到协同的作用。 Experiments show that the bacteriostatic composition provided by the invention has the effect of reducing the dosage of the rhubarb bacteriostatic agent at one time, and the combined use of the two drugs has a synergistic effect on inhibiting Micrococcus luteus.
实施例4 Example 4
1、大黄提取液的制备过程: 1. The preparation process of rhubarb extract:
同实施例1。 With embodiment 1.
2、水溶性银纳米颗粒制备 2. Preparation of water-soluble silver nanoparticles
同实施例1。 With embodiment 1.
4、大黄提取液与水溶性纳米银协同抑菌作用。 4. Synergistic antibacterial effect of rhubarb extract and water-soluble nano-silver.
a、细菌的培养 a. Culture of bacteria
挑取牛肉膏蛋白胨琼脂培养基上的藤黄微球菌单菌落于5mL牛肉膏蛋白胨液体培养基中,置于30℃培养箱中培养24h,再按1%的接种量接种于5mL的牛肉膏蛋白胨液体培养基中,30℃培12h后。取1mL上述菌液在用PBS与液体培养基按4:1比例混合的混合液中连续稀释三个梯度,最终的菌液大约为106~107CFU/mL。 Pick a single colony of Micrococcus luteus on the beef extract peptone agar medium, put it in 5mL beef extract peptone liquid medium, culture it in a 30°C incubator for 24 hours, and then inoculate 5mL of beef extract peptone according to the inoculation amount of 1%. In liquid medium, cultured at 30°C for 12h. Take 1mL of the above bacterial solution and serially dilute three gradients in the mixture of PBS and liquid medium at a ratio of 4:1, and the final bacterial solution is about 10 6 -10 7 CFU/mL.
b、水溶性纳米银与大黄提取液在抑菌性能上的协同作用 b. The synergistic effect of water-soluble nano-silver and rhubarb extract on antibacterial properties
分别取1mL上述已稀释好的菌液于1.5mL灭菌的离心管中,向1号离心管中分别加入400μL大黄提取液,向2号离心管中加入16μL浓度为10mg/mL的水溶性纳米银,向3号离心管中加入200μL大黄提取液和8μL水溶性纳米银,4号离心管作为空白对照,不加入任何上述抑菌剂。为保证每管液体最终体积相等,差量用PBS与液体培养基按4:1比例混合的混合液补齐。置于30℃摇床培养箱培养6h,每组实验平行三次。 Take 1 mL of the above-mentioned diluted bacterial solution in 1.5 mL sterilized centrifuge tubes, add 400 μL of rhubarb extract to No. 1 centrifuge tube, and add 16 μL of water-soluble nano Silver, add 200 μL of rhubarb extract and 8 μL of water-soluble nano-silver to No. 3 centrifuge tube, and No. 4 centrifuge tube is used as a blank control without adding any of the above-mentioned antibacterial agents. In order to ensure that the final volume of each tube of liquid is equal, the difference is made up with a mixture of PBS and liquid medium at a ratio of 4:1. Placed in a shaker incubator at 30°C for 6 hours, and each experiment was repeated three times.
c、平板计数 c. Plate count
将实验组待测液用PBS连续稀释两个梯度,10-1、10-2、10-3各取出100μL分别均匀涂 The solution to be tested in the experimental group was serially diluted in two gradients with PBS, and 100 μL of each of 10 -1 , 10 -2 , and 10 -3 was taken out and spread evenly.
布在牛肉膏蛋白胨固体平板上;空白组连续稀释四个梯度,从10-2、10-3、10-4三个梯度分别均匀涂布在牛肉膏蛋白胨固体平板上。平板吹干后,30℃倒置培养48h,长出菌落后计数,以20-200个菌落形成单位(CFU)为有效的计数范围。每毫升原菌液活菌数=平板计数*稀释倍数*10 Spread on the beef extract peptone solid plate; the blank group was serially diluted with four gradients, and spread evenly on the beef extract peptone solid plate from three gradients of 10 -2 , 10 -3 , and 10 -4 respectively. After drying the plate, culture it upside down at 30°C for 48 hours, count the colonies after they grow out, and take 20-200 colony forming units (CFU) as the effective counting range. The number of viable bacteria per milliliter of original bacterial solution = plate count * dilution factor * 10
如图4所示,图4a400μL大黄提取液对藤黄微球菌的抑制作用,图4b16μL的纳米银对藤黄微球菌的抑制作用,图4c200μL大黄提取液和8μL纳米银藤黄微球菌协同抑菌作用。 As shown in Figure 4, Figure 4a shows the inhibitory effect of 400 μL rhubarb extract on Micrococcus luteus, Figure 4b shows the inhibitory effect of 16 μL nano-silver on Micrococcus luteus, and Figure 4c shows the synergistic antibacterial effect of 200 μL rhubarb extract and 8 μL nano-silver on Micrococcus luteus effect.
实验表明:本发明提供的抑菌组合物具有减少大黄抑菌剂一次用量的作用,且两种药物的合用对抑制藤黄微球菌起到协同的作用。 Experiments show that the bacteriostatic composition provided by the invention has the effect of reducing the dosage of the rhubarb bacteriostatic agent at one time, and the combined use of the two drugs has a synergistic effect on inhibiting Micrococcus luteus.
Claims (3)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210366620.8A CN102895325B (en) | 2012-09-28 | 2012-09-28 | Traditional Chinese medicine bacteriostatic composition |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210366620.8A Division CN102895325B (en) | 2012-09-28 | 2012-09-28 | Traditional Chinese medicine bacteriostatic composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104013682A CN104013682A (en) | 2014-09-03 |
| CN104013682B true CN104013682B (en) | 2015-11-25 |
Family
ID=47568011
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410052640.7A Expired - Fee Related CN104013682B (en) | 2012-09-28 | 2012-09-28 | A kind of Traditional Chinese medicine bacteriostatic composition suppressing micrococcus luteus |
| CN201210366620.8A Expired - Fee Related CN102895325B (en) | 2012-09-28 | 2012-09-28 | Traditional Chinese medicine bacteriostatic composition |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210366620.8A Expired - Fee Related CN102895325B (en) | 2012-09-28 | 2012-09-28 | Traditional Chinese medicine bacteriostatic composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN104013682B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016018476A1 (en) | 2014-07-31 | 2016-02-04 | Kimberly-Clark Worldwide, Inc. | Anti-adherent alcohol-based composition |
| WO2016018474A1 (en) | 2014-07-31 | 2016-02-04 | Kimberly-Clark Worldwide, Inc. | Anti-adherent composition |
| US9969885B2 (en) | 2014-07-31 | 2018-05-15 | Kimberly-Clark Worldwide, Inc. | Anti-adherent composition |
| AU2014409811B2 (en) * | 2014-10-31 | 2021-02-18 | Kimberly-Clark Worldwide, Inc. | Anti-adherent botanical compositions |
| WO2016160006A1 (en) | 2015-04-01 | 2016-10-06 | Kimberly-Clark Worldwide, Inc. | Fibrous substrate for capture of gram negative bacteria |
| US12037497B2 (en) | 2016-01-28 | 2024-07-16 | Kimberly-Clark Worldwide, Inc. | Anti-adherent composition against DNA viruses and method of inhibiting the adherence of DNA viruses to a surface |
| CZ201699A3 (en) * | 2016-02-23 | 2017-04-12 | Univerzita Tomáše Bati ve Zlíně | Silver nanoparticles with improved properties, especially for environmentally friendly applications for sensors |
| AU2016408394B2 (en) | 2016-05-26 | 2021-11-11 | Kimberly-Clark Worldwide, Inc. | Anti-adherent compositions and methods of inhibiting the adherence of microbes to a surface |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090260258A1 (en) * | 2008-04-22 | 2009-10-22 | Peter Spiegel | Nano-silver footwear orthotic with insert and method of manufacture |
| CN102416054A (en) * | 2011-12-13 | 2012-04-18 | 成都默森医药开发有限公司 | A composition for treating onychomycosis and tinea manus and pedis |
| CN102579982A (en) * | 2012-03-05 | 2012-07-18 | 杨彦君 | Externally-applied patch of for local point to treat gynecologic pelvic inflammatory disease and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101054444B1 (en) * | 2008-11-13 | 2011-08-05 | 한국과학기술연구원 | Continuous production method of surface-modified nanoparticles using supercritical fluid and surface-modified nanoparticles prepared by the method |
| KR20110031574A (en) * | 2009-09-21 | 2011-03-29 | 전자부품연구원 | Method for producing silver nanoparticles and silver nanoparticles accordingly |
-
2012
- 2012-09-28 CN CN201410052640.7A patent/CN104013682B/en not_active Expired - Fee Related
- 2012-09-28 CN CN201210366620.8A patent/CN102895325B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090260258A1 (en) * | 2008-04-22 | 2009-10-22 | Peter Spiegel | Nano-silver footwear orthotic with insert and method of manufacture |
| CN102416054A (en) * | 2011-12-13 | 2012-04-18 | 成都默森医药开发有限公司 | A composition for treating onychomycosis and tinea manus and pedis |
| CN102579982A (en) * | 2012-03-05 | 2012-07-18 | 杨彦君 | Externally-applied patch of for local point to treat gynecologic pelvic inflammatory disease and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| Optimization of parameters for the synthesis of bimodal Ag nanoparticles;Sang Min Kim et al;《Journal of Industrial and Engineering Chemistry》;20091231(第15期);全文 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102895325B (en) | 2014-07-09 |
| CN102895325A (en) | 2013-01-30 |
| CN104013682A (en) | 2014-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104013682B (en) | A kind of Traditional Chinese medicine bacteriostatic composition suppressing micrococcus luteus | |
| CN110438091A (en) | A new Klebsiella pneumoniae phage and its application | |
| CN108378440A (en) | Chinese medicine antibacterial mask containing graphene oxide-copper silver nanoparticle compound | |
| CN104147076B (en) | Lonicera japonica antibacterial agent for restraining micrococcus luteus | |
| CN111407817A (en) | Traditional Chinese medicine composition for preventing respiratory tract infection pathogenic microorganisms and preparation method thereof | |
| CN102895341B (en) | Antibacterial Composition of Coptis Rhizoma Extract and Nano Silver | |
| CN108686045B (en) | A kind of naked flower purple pearl composition and its application in the treatment of pharyngitis | |
| Yadav et al. | In vitro Determination of Antibacterial Effect of Garlic (Allium sativum) on Staphylococcus aureus and E. coli | |
| CN111057681B (en) | A strain of bacteriophage and its application | |
| CN114931602A (en) | A kind of Chinese herbal medicine formula for inhibiting dairy cow-derived Escherichia coli and preparation method thereof | |
| CN108853358A (en) | A kind of antibacterial Chinese medicine composition and its preparation method and application | |
| CN114366779A (en) | Antiviral traditional Chinese medicine composition and mask | |
| CN102895282B (en) | Isatis root extracting solution and nano-silver bacteriostatic composition | |
| CN105963334A (en) | Great burdock fruit extract and preparation method thereof and application of great burdock fruit extract in bacteriostasis | |
| CN103815587B (en) | A kind ofly harmful fine particulates is effectively stoped in air to suck and mouth mask with bacteriostasis and preparation method thereof | |
| CN110638985A (en) | Chinese medicinal composition gel suppository for treating gynecological inflammation and preparation method thereof | |
| CN102895315B (en) | A nano-silver antibacterial composition containing forsythia extract | |
| CN116790713A (en) | A method and application of antibacterial screening of Passepartout extract | |
| CN109316533B (en) | Fermented traditional Chinese medicine compound preparation for removing endotoxin in pig body and application thereof | |
| CN108721167B (en) | Preservative composition containing Ampelopsis grossedentata extract and application of preservative composition in preparation of cosmetics | |
| CN115501288B (en) | Extraction method of callicarpa nudiflora extract and application of extract in resisting H1N1 virus | |
| CN115154487B (en) | Polysaccharide salt fog mixture containing probiotics fermentation liquor and used for protecting respiratory tract and application thereof | |
| CN114931599B (en) | A composition for inhibiting Staphylococcus aureus biofilm and its preparation method | |
| CN103977028A (en) | Antibacterial Composition of Sweet Potato Chlorogenic Acid and Nano Zinc Oxide | |
| CN107296858B (en) | A kind of antibacterial infection pharmaceutical composition and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180726 Address after: 071000 No. 4, unit 20, 20 geophysical exploration complex, 168 Fuxing Road, Xushui, Baoding, Hebei. Patentee after: Yin Liran Address before: 330031 999, Xuefu Avenue, Nanchang, Jiangxi. Patentee before: Nanchang University |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190129 Address after: 410300 No. 205 Luzhiyun Road, Liuyang Economic and Technological Development Zone, Hunan Province Patentee after: Anxin Biotechnology (Hunan) Co.,Ltd. Address before: 071000 No. 4, unit 20, 20 geophysical exploration complex, 168 Fuxing Road, Xushui, Baoding, Hebei. Patentee before: Yin Liran |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151125 |